You are here: Home: Meet The Professors Prostate Vol. 1 Issue 1: Faculty Affiliations and Disclosures

Faculty Affiliations

	Anthony V D’Amico, MD, PhD Professor and Chief of Genitourinary Radiation Oncology Brigham and Women's Hospital Dana-Farber Cancer Institute Harvard Medical School Boston, Massachusetts		William K Oh, MD Assistant Professor Department of Medicine, Harvard Medical School Associate Physician Department of Medicine, Brigham and Women's Hospital Clinical Director The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute Boston, Massachusetts
	Laurence Klotz, MD Professor of Surgery University of Toronto Chief, Division of Urology Sunnybrook Health Sciences Centre Toronto, Ontario		Daniel P Petrylak, MD Associate Professor of Medicine Director, Genitourinary Oncology Program The Columbia University Medical Center New York, New York
	Judd W Moul, MD Professor and Chief, Division of Urologic Surgery Director, Duke Prostate Center Duke University Medical Center Durham, North Carolina

CONTENT VALIDATION AND DISCLOSURES

Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved by a peer review content validation process. The content of each activity is reviewed by both a member of the scientific staff and an external independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

The scientific staff and consultants for Research To Practice are involved in the development and review of content for educational activities and report the following real or apparent conflicts of interest, either current or within the past 12 months, for themselves (or their spouses/partners) that have been resolved through a peer review process: Karen Green, MD, Richard Kaderman, PhD, Neil Love, MD, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack, PharmD, Erin Wall and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Aviva Asnis- Alibozek, PA-C, MPAS — salary: AstraZeneca Pharmaceuticals LP; shareholder of AstraZeneca Pharmaceuticals LP; Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc and Genentech BioOncology. Research To Practice receives education grants from Abraxis BioScience, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Genentech BioOncology/OSI Pharmaceuticals Inc, Genomic Health Inc, GPC Biotech, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational activities.

In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts of interest that have been resolved through a peer review process:

Dr D’Amico — No financial affiliations or interests to disclose. Dr Klotz — Consulting Fees: AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, Merck and Company Inc; Contracted Research and Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: AstraZeneca Pharmaceuticals LP. Dr Moul — Consulting Fees: AstraZeneca Pharmaceuticals LP; Contracted Research: GlaxoSmithKline; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: AstraZeneca Pharmaceuticals LP, Sanofi-Aventis; Ownership Interest: Theralogix LLC. Dr Oh — Consulting Fees: Dendreon, GPC Biotech, Johnson & Johnson Pharmaceuticals, Sanofi-Aventis; Contracted Research: Genentech BioOncology, Sanofi- Aventis; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: AstraZeneca Pharmaceuticals LP, Sanofi-Aventis. Dr Petrylak — Consulting Fees: Cell Genesys Inc, Sanofi-Aventis; Contracted Research: Celgene Corporation, GPC Biotech.

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

Community Panel

Martin K Dineen, MD Urologist Daytona Beach, Florida Atif M Hussein, MD Medical Oncologist Hollywood, Florida Alan M Nieder, MD Urologist Miami, Florida

Joseph F Pizzolato, MD Medical Oncologist Miami Beach, Florida Raul Ravelo, MD Radiation Oncologist Miami, Florida James A Reeves, MD Medical Oncologist Fort Myers, Florida

Michael A Simon, MD Urologist Pembroke Pines, Florida Srinath Sundararaman, MD Radiation Oncologist Hollywood, Florida Benjamin M Tripp, MD Urologist Boca Raton, Florida